STOCK TITAN

Clarivate Plc - CLVT STOCK NEWS

Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.

About Clarivate Plc

Clarivate Plc (NYSE: CLVT) is a leading global provider of transformative intelligence, delivering enriched data, insights, analytics, and workflow solutions to accelerate innovation across academia, intellectual property (IP), life sciences, and government sectors. With a mission to empower organizations and researchers to bring life-changing ideas to market faster, Clarivate offers a comprehensive suite of trusted brands, including Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor®, and Techstreet™. These solutions enable customers to streamline research, manage intellectual property, and optimize pharmaceutical development.

Core Business Areas

Clarivate operates across three primary segments:

  • Academia & Government: Supporting academic institutions and government bodies with data-driven insights, library services, and discovery platforms to enhance research and learning outcomes.
  • Intellectual Property: Providing tools for patent analytics, trademark research, and IP lifecycle management, empowering organizations to protect and monetize their innovations.
  • Life Sciences & Healthcare: Delivering real-world data, analytics, and workflow solutions to pharmaceutical and biotech companies, aiding in drug discovery, regulatory compliance, and market access.

Revenue Model and Market Position

Clarivate primarily generates revenue through subscription-based services, ensuring a predictable and recurring income stream. Its portfolio also includes licensing, transactional sales, and consulting services. With operations in over 100 countries and a customer base spanning academia, government, law, healthcare, and life sciences, Clarivate is uniquely positioned as a critical enabler of innovation. The company’s focus on integrating artificial intelligence (AI) and real-world data into its offerings distinguishes it from competitors in the knowledge economy.

Strategic Initiatives

Clarivate is actively pursuing a Value Creation Plan to enhance its financial performance and operational efficiency. Key initiatives include:

  • Subscription Revenue Growth: Transitioning from low-margin transactional products to high-margin subscription-based solutions.
  • Portfolio Rationalization: Streamlining its product offerings to focus on high-growth, high-impact areas.
  • AI-Driven Innovation: Leveraging advanced technologies like AI-powered patent search and real-world data analytics to enhance customer decision-making.
  • Sales Execution: Realigning account management models and investing in customer success teams to improve client engagement and retention.

Challenges and Opportunities

While Clarivate faces challenges such as fluctuating transactional revenues and market competition, its strategic focus on innovation and recurring revenue streams positions it for long-term growth. The company’s ability to integrate AI and real-world data into its solutions offers significant opportunities to address emerging customer needs and expand its market share.

Competitive Landscape

Clarivate competes with other data and analytics providers like Elsevier, Thomson Reuters, and Springer Nature. Its differentiation lies in its comprehensive suite of products, trusted brands, and commitment to innovation. By focusing on customer-centric solutions and leveraging advanced technologies, Clarivate continues to strengthen its competitive position.

Conclusion

Clarivate Plc is more than a data provider; it is a catalyst for innovation, enabling organizations to accelerate the journey from idea to impact. With a robust portfolio of solutions, a strategic focus on subscription revenue, and a commitment to leveraging cutting-edge technologies, Clarivate remains a pivotal player in the global knowledge economy.

Rhea-AI Summary

Clarivate Plc (NYSE:CLVT) has unveiled its Citation Laureates™ 2024 list, recognizing 22 exceptional scientists and economists from six countries whose work is considered of Nobel stature. These individuals have made significant contributions in areas such as clean energy, nanotechnology, 3D protein structures, and quantum computing. The list includes 11 researchers from the US, six from the UK, two from Switzerland, and one each from Germany, Israel, and Japan.

Clarivate's Institute for Scientific Information (ISI)™ has successfully identified 75 Citation Laureates prior to their Nobel success. The selection process is based on publication and citation data from the Web of Science™, focusing on authors whose papers have been cited more than 2,000 times. This year's laureates span fields including Physiology or Medicine, Physics, Chemistry, and Economics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.2%
Tags
none
-
Rhea-AI Summary

Clarivate Plc (NYSE:CLVT) has announced the full agenda for the 15th annual Clarivate Pharmavision India conference, scheduled for September 25-26, 2024, in Ahmedabad and Hyderabad. The event focuses on improving patient outcomes and building resilience in the healthcare ecosystem. Key topics include AI in healthcare, cell and gene therapy, and market access.

The conference aims to address challenges such as healthcare affordability and access in India. Industry leaders will discuss strategies for patient-centric innovation, R&D, generics, biosimilars, and healthcare manufacturing. Notable sessions will cover topics like balancing generics and innovation, AI's role in healthcare, and addressing barriers to cell and gene therapy integration in India.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.71%
Tags
none
-
Rhea-AI Summary

Clarivate Plc (NYSE:CLVT) has launched Primo™ Research Assistant, a generative AI-powered library discovery solution. Developed in collaboration with library partners, it offers students and researchers a seamless experience with natural language queries and immediate answers grounded in trusted sources. Key features include:

  • Semantic search and natural language queries
  • AI-powered answers with source references
  • Search suggestions for topic expansion
  • Multi-language support

The solution is built on a Retrieval Augmented Generation (RAG) architecture and utilizes the Ex Libris Central Discovery Index (CDI), containing over 5 billion records. The beta program, which began in June 2024, involved 18 institutions across 10 countries. Clarivate aims to responsibly apply AI in academia, fostering trust and innovation in research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.71%
Tags
AI
Rhea-AI Summary

Clarivate Plc (NYSE:CLVT) has released its first Pulse of the Library™ report, revealing insights on Artificial Intelligence (AI) implementation in libraries. The report, based on a survey of over 1,500 librarians worldwide, shows that:

- Over 60% of libraries are evaluating or planning for AI integration
- 43% prioritize AI-powered tools for users in the next 12 months
- Key AI goals include supporting student learning (52%), research excellence (47%), and content discoverability (45%)
- 42% believe AI can automate routine tasks, freeing librarians for strategic activities
- Challenges include shrinking budgets (47%) and lack of AI expertise (32% report no training available)

The report highlights regional differences in priorities and emphasizes the need for collaboration between IT experts and senior leadership to advance AI implementation in libraries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
none
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT), a global leader in transformative intelligence, has announced its participation in the upcoming Goldman Sachs Communacopia + Technology Conference. Jonathan Collins, Executive Vice President and Chief Financial Officer, will represent the company at the event on Thursday, September 12, 2024, at 8:50 am Pacific Time (11:50 am Eastern Time).

Interested parties can access the live webcast of the presentation through a provided link. For those unable to attend in real-time, a replay will be available on the same platform. Additionally, the presentation will be archived on Clarivate's investor relations website for 180 days, ensuring extended access for stakeholders and interested investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
conferences
-
Rhea-AI Summary

Clarivate Plc (NYSE:CLVT) has launched the Web of Science™ Research Assistant, a generative AI-powered tool designed to enhance research efficiency. Developed in partnership with the research community, this tool leverages the Web of Science Core Collection™ to help researchers:

  • Find key papers faster
  • Handle complex research tasks
  • Visualize connections in research fields

The Research Assistant offers flexible document searches, guided prompts, and unique data visualizations. It entered beta testing in December 2023 and was created in collaboration with librarians and researchers worldwide to ensure high standards of quality, accuracy, and privacy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.81%
Tags
AI
Rhea-AI Summary

Clarivate (NYSE: CLVT), a global provider of transformative intelligence, has appointed Melanie Margolin to the expanded role of Chief Administrative and Legal Officer.

Joining the company in September 2023 as Executive Vice President and Chief Legal Officer, Margolin will now oversee human resources, facilities, communications, and brand functions, in addition to global legal affairs, risk, sustainability, privacy, and compliance.

CEO Matti Shem Tov commended Margolin for her strategic insights and emphasis on talent development, reflecting her people-centric leadership style. Margolin expressed her commitment to fostering collaboration and growth at Clarivate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
none
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, has announced its participation in the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference. Jonathan Collins, Executive Vice President and Chief Financial Officer, will present on Monday, August 12, 2024, at 2:55 pm Eastern Time.

Investors and interested parties can access the live webcast of the presentation through a provided link. A replay of the webcast will be available on Clarivate's investor relations website for 90 days following the event. This presentation offers an opportunity for stakeholders to gain insights into Clarivate's current position and future strategies in the technology and information services sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.93%
Tags
conferences
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) has announced a significant leadership change. Matti Shem Tov, former CEO of ProQuest, will become the company's new CEO effective August 9, 2024, replacing Jonathan Gear. Shem Tov will also join the Board of Directors. Gear will transition to a non-executive role until November 1, 2024.

The Board and Gear mutually agreed on this transition, aiming to take Clarivate into its next phase of value creation. Under Gear's leadership, Clarivate restructured into three end-market segments, enhanced product innovation, and strengthened its balance sheet. The company is now positioned to leverage expertise within each business segment to deliver tailored solutions globally.

Shem Tov's appointment is expected to accelerate Clarivate's organic growth, leveraging his experience in product innovation and market delivery. The change comes as Clarivate reported its second quarter 2024 results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.2%
Tags
management
Rhea-AI Summary

Clarivate (NYSE: CLVT) reported its Q2 2024 financial results, showing a 2.8% revenue decrease to $650.3 million. Organic revenues dipped 0.6%, with an increase of 0.7% in subscription revenues offset by declines in re-occurring and transactional revenues.

The company posted a net loss of $304.3 million, with adjusted net income down 6.6% to $142.2 million. Adjusted diluted EPS fell 4.8% to $0.20. Adjusted EBITDA decreased by 3.7% to $274.4 million, with a margin contraction to 42.2%.

For the six months ending June 30, 2024, revenues totaled $1.27 billion, a 2% decline. Net loss for this period was $379.3 million, and adjusted net income dropped 13.2% to $245.7 million. Adjusted diluted EPS was down 12.8% to $0.34. Adjusted EBITDA was $510.7 million, a 5% decrease.

Free cash flow plummeted by $44.5 million in Q2 to $60.3 million and by $100.9 million for the first half of the year to $172.1 million.

The company reaffirmed its 2024 outlook and highlighted new product launches and positive customer responses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.2%
Tags

FAQ

What is the current stock price of Clarivate Plc (CLVT)?

The current stock price of Clarivate Plc (CLVT) is $4.29 as of February 28, 2025.

What is the market cap of Clarivate Plc (CLVT)?

The market cap of Clarivate Plc (CLVT) is approximately 3.0B.

What does Clarivate Plc do?

Clarivate provides data, insights, and workflow solutions to accelerate innovation in academia, intellectual property, and life sciences.

How does Clarivate generate revenue?

Clarivate primarily generates revenue through subscription-based services, licensing, and consulting, ensuring a recurring income stream.

What industries does Clarivate serve?

Clarivate serves academia, government, intellectual property, life sciences, and healthcare sectors, offering tailored solutions for each industry.

What are Clarivate’s key brands?

Clarivate’s key brands include Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor®, and Techstreet™.

What is Clarivate’s Value Creation Plan?

The Value Creation Plan focuses on subscription revenue growth, portfolio rationalization, AI-driven innovation, and improved sales execution.

How does Clarivate use AI in its products?

Clarivate integrates AI into solutions like patent search and real-world data analytics to enhance decision-making and innovation workflows.

What challenges does Clarivate face?

Clarivate faces challenges such as fluctuating transactional revenues, market competition, and the need for continuous product innovation.

Who are Clarivate’s competitors?

Clarivate competes with companies like Elsevier, Thomson Reuters, and Springer Nature in the data and analytics space.

What makes Clarivate unique?

Clarivate’s comprehensive product portfolio, trusted brands, and focus on AI-driven innovation set it apart from competitors.

What are Clarivate’s future growth areas?

Clarivate aims to grow through subscription-based solutions, AI-powered innovation, and expanding its presence in high-impact sectors like life sciences.
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Stock Data

3.04B
366.77M
16.38%
92.68%
6.23%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United Kingdom
ST. HELIER